These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17545773)

  • 1. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
    Danese S
    Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.
    Danese S; Sans M; de la Motte C; Graziani C; West G; Phillips MH; Pola R; Rutella S; Willis J; Gasbarrini A; Fiocchi C
    Gastroenterology; 2006 Jun; 130(7):2060-73. PubMed ID: 16762629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
    Hatoum OA; Heidemann J; Binion DG
    Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets: new players in the mucosal scenario of inflammatory bowel disease.
    Danese S; Scaldaferri F; Papa A; Pola R; Sans M; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):193-8. PubMed ID: 15638229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'.
    Danese S
    Gut; 2011 Jul; 60(7):998-1008. PubMed ID: 21212253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation.
    Lust M; Vulcano M; Danese S
    Trends Mol Med; 2008 Jun; 14(6):237-44. PubMed ID: 18457995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.
    Scaldaferri F; Sans M; Vetrano S; Graziani C; De Cristofaro R; Gerlitz B; Repici A; Arena V; Malesci A; Panes J; Grinnell BW; Danese S
    J Clin Invest; 2007 Jul; 117(7):1951-60. PubMed ID: 17557119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease.
    Binion DG; Rafiee P
    Gastroenterology; 2009 Feb; 136(2):400-3. PubMed ID: 19111728
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel pathogenic role for microvasculature in inflammatory bowel disease.
    Danese S; Papa A; Scaldaferri F; Graziani C; Bonizzi M; Armuzzi A; Fedeli G; Gasbarrini G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2006; 10(1):3-5. PubMed ID: 16494103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in inflammatory bowel disease.
    Pousa ID; Maté J; Gisbert JP
    Eur J Clin Invest; 2008 Feb; 38(2):73-81. PubMed ID: 18226040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
    Chidlow JH; Shukla D; Grisham MB; Kevil CG
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of probiotics.
    Boirivant M; Strober W
    Curr Opin Gastroenterol; 2007 Nov; 23(6):679-92. PubMed ID: 17906447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulators of angiogenesis in inflammatory bowel disease: thrombospondin in the spotlight.
    Danese S
    Pathobiology; 2008; 75(1):22-4. PubMed ID: 18334836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological basis of inflammatory bowel disease: role of the microcirculation.
    Laroux FS; Grisham MB
    Microcirculation; 2001 Oct; 8(5):283-301. PubMed ID: 11687942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: thromboxanes in inflammatory bowel disease--pathogenic and therapeutic implications.
    Rampton DS; Collins CE
    Aliment Pharmacol Ther; 1993 Aug; 7(4):357-67. PubMed ID: 8218751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonimmune cells in inflammatory bowel disease: from victim to villain.
    Danese S
    Trends Immunol; 2008 Nov; 29(11):555-64. PubMed ID: 18838297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
    Atreya R; Atreya I; Neurath MF
    Ann N Y Acad Sci; 2006 Aug; 1072():98-113. PubMed ID: 17057193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.